|
September 2007
(This document available in PDF, 337 KB)
Live Audio Webcast
Federal Register Notice
Monday, September 10, 2007 | |
---|---|
8:00 - 9:00 am | Registration Continental breakfast |
9:00 - 9:30 am | Welcome and Overview of Meeting with Objectives Michael Landa – Deputy Director, CFSAN |
Setting the Stage: Regulatory Framework Barbara Schneeman – Director, Office of Nutrition, Labeling, and Dietary Supplements |
|
9:30 - 11:00 am
Panel 1 |
The International Experience - Government Activities FDA moderator – Leslye Fraser, Director, Office of Regulations, Policy, and Social Sciences Presenters:
Discussant: Brazil, National Health Surveillance Agency - Ana Paula Rezende Peretti Q & A with FDA panel |
11:00 - 11:30 am | Break |
11:30 am - 1:00 pm
Panel 2 |
The International Experience - Research and Other Perspectives FDA moderator - Leslye Fraser Presenters:
Discussant: Food Standards Australia - Trevor Webb Q & A with FDA panel |
1:00 - 2:00 pm | Lunch (facilities available onsite) |
2:00 - 3:30 pm
Panel 3 |
U.S. Experience - Manufacturer Activities FDA moderator – Barbara Schneeman Presenters:
Discussant: Institute of Medicine - Linda Myers Q & A with FDA panel |
3:30 - 4:00 pm | Break |
4:00 - 5:30 pm
Panel 4 |
U.S. Experience - Research and Other Perspectives FDA moderator – Barbara Schneeman Presenters:
Discussant: The Keystone Center - Brad Sperber Q & A with FDA panel |
5:30 - 6:30 pm | Reception |
Tuesday, September 11, 2007 | |
8:00 - 9:00 am | Registration Continental breakfast |
9:00 - 10:30 am
Panel 5 |
U.S. Experience - Research and Other Perspectives FDA moderator – Michael Landa Presenters:
Q & A with FDA panel |
10:30 - 11:00 am | Break |
11:00 am - 12:30 pm
Panel 6 |
U.S. Experience - Research and Other Perspectives FDA moderator – Michael Landa Presenters:
Q & A with FDA panel |
12:30 - 1:30 pm | Lunch (facilities available onsite) |
1:30 - 3:00 pm
Panel 7 |
Public comments and Final FDA questions/comments FDA moderator – Michael Landa Registered commenters:
|
3:00 - 3:30 pm | Break (if necessary) |
3:30 - 5:00 pm | Public comments continued (if necessary)
Final FDA questions and concluding remarks FDA moderator - Michael Landa FDA PANELISTS:
|